First-line therapy: insights from a real-world analysis of cryoablation in patients with atrial fibrillation

J Cardiovasc Med (Hagerstown)

21 May May 2021 one month ago
  • Moltrasio M, Tondo C

Pulmonary vein isolation (PVI) using cryoballoon ablation (CBA) is mainly reserved for patients with drug-refractory or drug-intolerant symptomatic atrial fibrillation. We evaluated a large cohort of patients treated in a real-world setting and examined the safety and efficacy profile of CBA when applied as a first-line treatment for atrial fibrillation.

Reference

Moltrasio M, Iacopino S, Arena G, Pieragnoli P, Molon G, Manfrin M, Verlato R, Ottaviano L, Rovaris G, Catanzariti D, Cipolletta L, Nicolis D, Cattafi G, Tondo C; 1STOP ClinicalService centers. First-line therapy: insights from a real-world analysis of cryoablation in patients with atrial fibrillation. J Cardiovasc Med (Hagerstown) 2021 Mar 23. doi: 10.2459/JCM.0000000000001176.

Go to PubMed